Mimedx (MDXG) Cash from Investing Activities Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash from Investing Activities Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 0.00% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | 28.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.41% |
| Mar 31, 2026 | -1,289.66% |
| Dec 31, 2025 | 87.89% |
| Sep 30, 2025 | -4,753.10% |
| Jun 30, 2025 | 1.99% |
| Mar 31, 2025 | 93.26% |
| Dec 31, 2024 | -475.26% |
| Sep 30, 2024 | 117.41% |
| Jun 30, 2024 | -160.06% |
| Mar 31, 2024 | -789.81% |
| Dec 31, 2023 | 71.85% |
| Sep 30, 2023 | -73.53% |
| Jun 30, 2023 | 18.88% |
| Mar 31, 2023 | -357.43% |
| Dec 31, 2022 | -444.27% |
| Sep 30, 2022 | 35.52% |
| Jun 30, 2022 | -1.66% |
| Mar 31, 2022 | 92.88% |
| Dec 31, 2021 | 86.19% |
| Sep 30, 2021 | 18.31% |